Leading stock 6 days 4 boards Weekly list of A-share companies disclosing M&A restructuring progress

The A-share market continues to see active mergers and acquisitions. As of Friday’s close, assets and liabilities related to real estate development are being transferred to controlling shareholders by Jingtou Development, which has hit the daily limit four times in six days. It plans to purchase 100% of Haicheng Ruihai and 80% of Electric Power Investment Ruixiang with cash payments, under Dongfang Xinneng, which has hit the daily limit three times in five days. It also plans to acquire 70% of Ude New Energy, a new energy operation and maintenance company, through Zhaoxin Shares; to buy 100% of Fuyue Technology for 240.6 million yuan; and to acquire at least 40% of Qunjian Aviation through a wholly owned subsidiary, with Hengtian Hailong hitting the daily limit涨停.

According to incomplete statistics from Caixin, as of press time, 17 A-share listed companies have disclosed progress in mergers and acquisitions this week, including Defu Technology, Puran Shares, Jiemite, Jingfeng Mingyuan, Shouhua Gas, China Duty Free, Dashengda, Heshun Petroleum, Watson Biotech, Oriental Yuhong, Shapu Aisi, Kute Intelligent, Huitong Energy, Shentong Express, Jiemei Technology, Fulaise, Gaoling Information. The details are shown in the chart below:

Among them, Dashengda announced a cross-industry investment on Wednesday, and its stock hit the daily limit for three consecutive days. Dashengda announced that it plans to invest a total of 550 million yuan through equity transfer and capital increase to acquire a 22.9831% stake in Xintong Semiconductor Technology (Xiamen) Co., Ltd.. Specifically, 27.86 million yuan will be used to acquire 2.7074%, and 22.14 million yuan for 1.5961%, with a 500 million yuan capital increase (divided into two rounds: 250 million yuan in the first round, and 250 million yuan in the second, contingent on successful wafer production). Meanwhile, the controlling shareholder Xinxingda will also invest 50 million yuan under the same conditions to obtain 1.9608%.

Xintong Semiconductor was established in 2019 and is a pioneer in China focused on designing, developing, and selling general-purpose high-performance graphics processing unit chips. On March 13, Xintong Semiconductor announced on its official website that the company launched a private domain super AI infrastructure TokenClaw super AI system for enterprises, built on two core engines: the self-developed AI agent framework based on OpenClaw and the TokenLake multi-agent AI application system, creating an internal closed-loop shrimp farming ecosystem—self-farming and self-consuming, healthy and harmless.

Shapu Aisi announced on Tuesday that after acquiring assets from its controlling shareholder, its stock hit the daily limit on Wednesday. Shapu Aisi stated that it plans to acquire 100% of Shanghai Qinli held by controlling shareholder Yanghe Industrial and its concerted action Yihe Medical for 528 million yuan in cash. After the transaction, the company will indirectly hold 100% of Shanghai Tianlun Hospital. The company said this aligns with its “pharmaceutical + medical” dual-driven strategy, enhances profitability and risk resistance, and is an important measure for the actual controller to fulfill commitments to resolve industry competition. It emphasized that Tianlun Hospital is a high-quality target with outstanding profitability.

Notably, on the same day, the company received an inquiry letter from the Shanghai Stock Exchange due to the valuation increase rate of the target company exceeding 24 times. The SSE requested the company to provide additional disclosures on four core issues: the reasonableness of the transaction valuation, the achievability of performance commitments, sources of funds and payment ability, and the ownership and operational qualifications of the target assets. The company must respond in writing within five trading days and fulfill its disclosure obligations.

According to incomplete statistics, this week, several listed companies that disclosed merger and acquisition progress have suspended or resumed trading, including Watson Biotech, Jiemei Technology, and Gaoling Information. Watson Biotech announced that it is planning to issue shares to Tengyun Xinwo at a price of 9.63 yuan per share, raising no more than 2.003 billion yuan, with all funds used to supplement working capital after deducting issuance costs. After issuance, Tengyun Xinwo will hold 11.51%, and its concerted action will hold 14.46%, with the company’s controlling shareholder changing to Tengyun Xinwo and the actual controller to Huang Tao. The stock resumed trading on March 19. Jiemei Technology plans to acquire 100% of Changsha Efuosi Technology Co., Ltd. through share issuance, with trading resuming on March 17. Gaoling Information plans to acquire control of satellite communications company Kairui Xingtong, which is expected to constitute a major asset restructuring; its stock has been suspended since March 17, 2026, with an expected suspension period of no more than 10 trading days.

(Source: Caixin)